516
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Liver Enzymes and Lipid Profile of Malaria Patients Before and After Antimalarial Drug Treatment at Dembia Primary Hospital and Teda Health Center, Northwest, Ethiopia

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 11-23 | Published online: 28 Mar 2022

References

  • Latif A, Mansha M, Saif K, Fatima S. Histopathological effects of different artemisinin derivatives on liver of male albino mice. J Anim Plant Sci. 2018;28(6):1701–1708.
  • Barber BE, Rajahram GS, Grigg MJ, William T, Anstey NM. World malaria report: time to acknowledge Plasmodium knowlesi malaria. Malar J. 2017;16(1):1–3. doi:10.1186/s12936-017-1787-y
  • Onyesom I, Onyemakonor N. Levels of parasitaemia and changes in some liver enzymes among malarial infected patients in edo-delta region of Nigeria. Curr Res J Biol Sci. 2011;3(2):78–81.
  • Sharma C, Awasthi SK. Recent advances in antimalarial drug discovery—challenges and opportunities. In: An Overview of Tropical Diseases. 2015:39.
  • World Health Organization. World malaria report 2020: 20 years of global progress and challenges. J Malar. 2020:2020:1–51.
  • Taffese HS, Hemming-Schroeder E, Koepfli C, et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect Dis Poverty. 2018;7(1):1–9. doi:10.1186/s40249-018-0487-3
  • Deress T, Girma M. Plasmodium falciparum and Plasmodium vivax Prevalence in Ethiopia: a systematic review and meta-analysis. Malar Res Treat. 2019;2019:12.
  • Alemu A, Abebe G, Tsegaye W, Golassa L. Climatic variables and malaria transmission dynamics in Jimma town, South West Ethiopia. Parasit Vectors. 2011;4(1):30. doi:10.1186/1756-3305-4-30
  • Augustine O. Effect of Plasmodium falciparum on liver function parameters of children in Akoko Area of Ondo State, Nigeria. J Diagn. 2018;5(1):1–5. doi:10.18488/journal.98.2018.51.1.5
  • Hoekstra LT, de Graaf W, Nibourg GA, et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257(1):27–36. doi:10.1097/SLA.0b013e31825d5d47
  • Wunderlich F, Al-Quraishy S, Dkhil MA. Liver-inherent immune system: its role in blood-stage malaria. Front Microbiol. 2014;5:559. doi:10.3389/fmicb.2014.00559
  • Krücken J, Dkhil MA, Braun JV, et al. Testosterone suppresses protective responses of the liver to blood-stage malaria. Infect Immun. 2005;73(1):436–443. doi:10.1128/IAI.73.1.436-443.2005
  • Faucher J-F, Ngou-Milama E, Missinou M, Ngomo R, Kombila M, Kremsner PG. The impact of malaria on common lipid parameters. Parasitol Res. 2002;88(12):1040–1043. doi:10.1007/s00436-002-0712-6
  • Kochar D, Agarwal P, Kochar S, et al. Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. Int J Med. 2003;96(7):505–512.
  • Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Cmaj. 2005;172(3):367–379. doi:10.1503/cmaj.1040752
  • Al-Salahy M, Shnawa B, Abed G, Mandour A, Al-Ezzi A. Parasitaemia and its relation to hematological parameters and liver function among patients malaria in Abs, Hajjah, Northwest Yemen. Interdiscip Perspect Infect Dis. 2016:2016. doi:10.1155/2016/5954394
  • Fabbri C, de Cássia Mascarenhas-netto R, Lalwani P, et al. Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Malar J. 2013;12(1):1–7. doi:10.1186/1475-2875-12-315
  • Mohanty S, Mishra S, Das B, et al. Altered plasma lipid pattern in falciparum malaria. Ann Trop Med Parasitol. 1992;86(6):601–606. doi:10.1080/00034983.1992.11812715
  • Jiang J, Nilsson-Ehle P, Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis. 2006;5(1):1–7. doi:10.1186/1476-511X-5-4
  • Sibmooh N, Yamanont P, Krudsood S, et al. Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules. Lipids Health Dis. 2004;3(1):15. doi:10.1186/1476-511X-3-15
  • Lopes-Virella M, Wohltmann H, Loadholt C, Buse M. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia. 1981;21(3):216–223. doi:10.1007/BF00252657
  • Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D. The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes. 1983;32(6):525–531. doi:10.2337/diab.32.6.525
  • Visser BJ, Wieten RW, Nagel IM, Grobusch MP. Serum lipids and lipoproteins in malaria-a systematic review and meta-analysis. Malar J. 2013;12(1):442. doi:10.1186/1475-2875-12-442
  • Tran PN, Brown SH, Rug M, Ridgway MC, Mitchell TW, Maier AG. Changes in lipid composition during sexual development of the malaria parasite Plasmodium falciparum. Malar J. 2016;15(1):1–13. doi:10.1186/s12936-016-1130-z
  • Khovidhunkit W, Kim M-S, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169–1196. doi:10.1194/jlr.R300019-JLR200
  • Edikpo N, Okonkwo PO, Adikwu E. Effect of artemether treatment on plasma lipid profile in malaria. Pharmacol Pharm. 2014;5(07):646. doi:10.4236/pp.2014.57074
  • World Health Organization. Guidelines for the treatment of malaria: World Health Organization; 2015.
  • Enato EF, Okhamafe AO. Plasmodium falciparum malaria and antimalarial interventions in sub-Saharan Africa: challenges and Opportunities. Afr J Biotech. 2005;4:13.
  • Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T. Therapeutic efficacy of artemether/lumefantrine (Coartem®) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors. 2010;3(1):1–9. doi:10.1186/1756-3305-3-1
  • Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731–739. doi:10.1056/NEJMra052270
  • Ugokwe C, Asomba H, Onwuzulike I. Hepatotoxicity potential of coartemether on Wistar albino rat using liver enzyme assay. J Pharm Biol Sci. 2015;10:66–70.
  • Alemu A, Muluye D, Mihret M, Adugna M, Gebeyaw M. Ten year trend analysis of malaria prevalence in Kola Diba, North Gondar, Northwest Ethiopia. Parasit Vectors. 2012;5(1):1–6. doi:10.1186/1756-3305-5-173
  • Addisu A, Tegegne Y, Mihiret Y, Setegn A, Zeleke AJ. A 7-year trend of malaria at primary health facilities in Northwest Ethiopia. J Parasitol Res. 2020;2020. doi:10.1155/2020/4204987
  • World Health Organization. Methods for surveillance of antimalarial drug efficacy; 2009.
  • Mathison BA, Pritt BS. Update on malaria diagnostics and test utilization. J Clin Microbiol. 2017;55(7):2009–2017. doi:10.1128/JCM.02562-16
  • Adewoyin A. Peripheral blood film-a review. Ann Ib Postgrad Med. 2014;12(2):71–79.
  • Oyewole I, Senusie S, Mansaray M. Plasmodium falciparum-induced kidney and liver dysfunction in malaria patients in Freetown, Sierra Leone. Sierra Leone J Biomed Res. 2010;2(1):70–74. doi:10.4314/sljbr.v2i1.56611
  • Warjri SB, Ete T, Mishra A, et al. Association between clinical malaria and blood lipids in north eastern India. J Adv Med Med Res. 2016;16:1–7.
  • Bush V, Smola C, Schmitt P. Evaluation of the Beckman Coulter DxC 700 AU chemistry analyzer. Pract Lab Med. 2020;18:e00148. doi:10.1016/j.plabm.2019.e00148
  • Gurjeet Singh R, Maheshwari U, Samant P. Role of liver enzymes in patients infected with Plasmodium vivax and Plasmodium falciparum. Int J Adv Microbiol Health Res. 2018;2(1):650–654.
  • Sirak S, Fola AA, Worku L, Biadgo B. Malaria parasitemia and its association with lipid and hematological parameters among malaria-infected patients attending at Metema Hospital, Northwest Ethiopia. Pathol Lab Med Int. 2016;8:43–50. doi:10.2147/PLMI.S118946
  • Dias RM, Vieira JLF, BdC C, et al. Lipid profile of children with malaria by Plasmodium vivax. J Trop Med. 2016;2016. doi:10.1155/2016/9052612
  • Ebenezer D-IO. Evaluation of some biochemical parameters of Plasmodium falciparum infected inhabitants of Ekpoma Metropolis, Nigeria. Adv Biomed Sci. 2018;3(1):1.
  • Kiru A, Bala R, Abdulazeez A, et al. Lipid profile and electrolyte level in malaria patients attending Muhammadu Abdullahi Wase Specialist Hospital, Kano State, Nigeria. JComplement Altern Med Res. 2018;5(4):1–7. doi:10.9734/JOCAMR/2018/41215
  • Mannu A, Agarwalla SK, Vasudevan J, Subramaniam K, Ahamed Basha A. Hepatic dysfunction in children with complicated malaria. Int J Contemp Pediatr. 2018;5(2):5–28. doi:10.18203/2349-3291.ijcp20180552
  • Visser BJ, de Vries SG, Vingerling R, et al. Serum lipids and lipoproteins during uncomplicated malaria: a cohort study in Lambarene, Gabon. Am J Trop Med Hyg. 2017;96(5):1205–1214. doi:10.4269/ajtmh.16-0721
  • Jacob EA. Assessment of altered plasma lipid pattern in Plasmodium falciparum malaria infected and non infected individuals. Int J Hematol Disord. 2014;1:27–30.
  • Kullu BK, Majhi C, Pradhan B, Swain DK. Lipid profiles among Plasmodium falciparum infected, non malarial febrile patients and volunteers. Int J Adv Med. 2018;5(3):556. doi:10.18203/2349-3933.ijam20181661